Clinical trial
a Proof of Principle in Vivo Study to Evaluate the Anti-Calculus and Safety Profile of a Novel Enzyme Formulation
NCT06139835 is registered in ClinicalTrials.gov with Pontis Biologics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- a Proof of Principle in Vivo Study to Evaluate the Anti-Calculus and Safety Profile of a Novel Enzyme Formulation
- Lead sponsor
- Pontis Biologics, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 8, 2022
- Completion date
- July 6, 2022
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.